Antibe Therapeutics Inc. announced the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized gastroenterologists. The three appointees are: Dr. Francis Chan, Professor of Medicine at The Chinese University of Hong Kong; Dr. Angel Lanas, Professor of Medicine, University of Zaragoza (Spain); and Dr. James Scheiman, Professor of Internal Medicine at the University of Michigan. The company also announced that Jeremy Grushcow, Ph.D., J.D. has moved to a full-time position as EVP, Strategic Development.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 CAD | -.--% | -.--% | -68.28% |
Apr. 24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
Apr. 19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
1st Jan change | Capi. | |
---|---|---|
-68.28% | 11.47M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
+0.09% | 21.96B | |
-8.24% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ATE Stock
- News Antibe Therapeutics Inc.
- Antibe Therapeutics Inc. Announces the Formation of its Clinical Advisory Board